Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Fourcade

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductaseJulianne L Holleran, Julien Fourcade, Merrill J Egorin, et al.
JCI Insight|July 27, 2018
CD226 opposes TIGIT to disrupt Tregs in melanomaJulien Fourcade, Zhaojun Sun, Joe-Marc Chauvin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancersBratislav Janjic, Pedro Andrade, Xiao-Fei Wang, et al.
Cancer Research|December 18, 2013
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccinesJulien Fourcade, Zhaojun Sun, Ornella Pagliano, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
In vitro metabolism of the phosphatidylinositol 3-kinase inhibitor, wortmannin, by carbonyl reductaseJulianne L Holleran, Julien Fourcade, Merrill J Egorin, et al.
JCI Insight|July 27, 2018
CD226 opposes TIGIT to disrupt Tregs in melanomaJulien Fourcade, Zhaojun Sun, Joe-Marc Chauvin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancersBratislav Janjic, Pedro Andrade, Xiao-Fei Wang, et al.
Cancer Research|December 18, 2013
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccinesJulien Fourcade, Zhaojun Sun, Ornella Pagliano, et al.
Pageof 2